Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 17/20 | 0.52 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL633414 | 0.94 | CCR2 (0.47) | CCR2DDR1ALDH1A1POLBCYP2D6 | |
| SCHEMBL634339 | 0.89 | CCR2 (0.52) | CCR2 | |
| SCHEMBL628694 | 0.84 | CCR2 (0.48) | CCR2KCNH2 | |
| SCHEMBL629448 | 0.80 | CCR2 (0.41) | CCR2KCNH2 | |
| SCHEMBL613106 | 0.77 | CCR2 (0.75) | CCR2KCNH2 | |
| SCHEMBL633107 | 0.74 | CCR2 (0.51) | CCR2CYP2D6KCNH2 | |
| SCHEMBL629157 | 0.73 | CCR2 (0.48) | CCR2ALDH1A1POLBCYP2D6KCNH2 | |
| Trifluoroacetic Acid SCHEMBL632228 | 0.73 | CCR2 (0.60) | CCR2ALDH1A1POLBKCNH2 | |
| SCHEMBL628210 | 0.73 | CCR2 (0.49) | CCR2CYP2D6KCNH2 | |
| SCHEMBL2486988 | 0.72 | CCR2 (0.53) | CCR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2419419-A1 | 4-AZETIDINYL-1-PHENYL-CYCLOHEXANE ANTAGONISTS OF CCR2 | Janssen Pharmaceutica, N.V. (BE) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010121046-A1 | 4-AZETIDINYL-1-PHENYL-CYCLOHEXANE ANTAGONISTS OF CCR2 | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-21 | — | — | WO | disclosed |